Searchable abstracts of presentations at key conferences in endocrinology

ea0020p155 | Thyroid | ECE2009

Iodine metabolism in hyperthyroidism

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria , Chrapko Beata

Introduction: Iodine is critical for thyroid morphology and function. On the one hand, iodine is a factor leading and permitting to origin of disturbances of thyroid follicular cells function, on the other hand, it’s therapeutic agent.Aim: The aim of the study was to evaluate iodine metabolism in different forms of hyperthyroidism and to analyze relationship between metabolism and thyroid size and function.Material and methods...

ea0011p281 | Diabetes, metabolism and cardiovascular | ECE2006

Myocardial ischemia in type 1 diabetic patients – re-examination after four years

Kowalczyk M , Chrapko B , Zaorska-Rajca J , Tarach JS , Nowakowski A

The silent myocardial ischemia is a serious diagnostic problem especially in patients with long-standing diabetes of type 1 (DM). Resting as well as exercise myocardial perfusion scintigraphy tests allow to recognize the silent myocardial ischemia in these groups of patients and to start the relevant treatment. The aim of the study was to establish the prevalence of myocardial ischemia in patients with type 1 DM, without clinical symptoms of ischemic heart disease (IHD) and wi...

ea0041ep1069 | Thyroid (non-cancer) | ECE2016

The efficacy of Radioiodine Therapy in Patients with Graves’ Disease

Dabrowska Anna , Kijek Jolanta , Tarach Jerzy , Torun-Jurkowska Anna , Chrapko Beata , Kurowska Maria

Introduction: Radioiodine (RAI) has been used for the treatment of Graves’ hyperthyroidism since 1940s. It is relatively safe and considered as one of the definitive therapies. Achievement of hypothyroidism or euthyroidism is defined as a successful therapy.Methods: The study was conducted in 366 patients (80.60% of women) with Graves’ disease (GD), aged 46.76±13.52 years. We analyzed retrospectively hormonal and imaging findings (scintigr...

ea0041ep1081 | Thyroid (non-cancer) | ECE2016

The efficacy of radioiodine therapy in patients with hyperfunctioning thyroid nodules

Dabrowska Anna , Kijek Jolanta , Tarach Jerzy , Torun-Jurkowska Anna , Chrapko Beata , Kurowska Maria

Introduction: Radioiodine (RAI) is used as a definitive therapy of hyperthyroidism due to toxic adenoma (TA) as well as toxic multinodular goiter (TMG). Achievement of hypothyroidism or euthyroidism is defined as a successful therapy.Methods: The study was conducted in 666 patients – 484 with TA and 182 with TMG (85.58% of women), aged 56.19±13.88 years. We analyzed retrospectively hormonal and imaging findings (scintigraphy, ultrasonography), ...

ea0035p566 | Endocrine tumours and neoplasia | ECE2014

Primary neuroendocrine carcinoma of renal: a rare case report

Budlewski Tadeusz , Szydlarska Dorota , Szalus Norbert , Kijek Jolanta , Chrapko Beata Ewa

We report a case of local recurrence and multiple lymph node and pulmonary metastases of renal carcinoid 1 year after nephrectomy in a 61-year-old woman. Primary renal carcinoid tumor arising from renal parenchyma or renal pelvis is a rare neoplasm. The patient was incidentally found to have a mass lesion in the left kidney and left nephrectomy was performed. Histological examination including immunohistochemical for chromogranin A and synaptophysin studies confirmed the diagn...

ea0022p814 | Thyroid | ECE2010

Age and size of goitre in hyperthyroidism

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria , Jankowska Helena , Chrapko Beata , Dabrowska Anna

Aim: The aim of the study was to evaluate the patients’ age and goitre size in relation to the form of hyperthyroidism, as well as the relationship between patients’ age and goitre size and function.Material and methods: The subject group included 484 patients (420 females and 64 males) with hyperthyroidism. Graves’ disease (GD) was diagnosed in 171 subjects and toxic nodular goitre (TNG) was found in 313 subjects. FT3, fT4...

ea0022p830 | Thyroid | ECE2010

TSH receptor antibody levels (TSHAb) in hyperthyroid patients with Graves’ disease (GD): an evaluation of the outcome of 131I therapy

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria , Szymanek Bozena , Chrapko Beata , Dabrowska Anna

Aim: The aim of the study was to evaluate the relationship between TSHAb levels and thyroid function and size in patients with Graves’ disease and then to estimate the influence of TSHAb on the outcome of 131I therapy.Material and methods: Two hundred and one patients (168 females and 33 males, mean age 47.76 years, range 18–84) with Graves’ disease were enrolled. Before therapy, plasma fT3, fT4, TSH (DELFI...